Chemoinformaics analysis of Icosahydropicenic acid
| Molecular Weight | 342.523 | nRot | 1 |
| Heavy Atom Molecular Weight | 308.251 | nRig | 27 |
| Exact Molecular Weight | 342.256 | nRing | 5 |
| Solubility: LogS | -4.575 | nHRing | 0 |
| Solubility: LogP | 6.226 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 62.685 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.652 |
| Synth | 4.236 |
| Natural Product Likeliness | 1.184 |
| NR-PPAR-gamma | 0.3 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.942 |
| Pgp-sub | 0 |
| HIA | 0.025 |
| CACO-2 | -4.824 |
| MDCK | 0.0000689 |
| BBB | 0.026 |
| PPB | 0.988315 |
| VDSS | 1.091 |
| FU | 0.00513104 |
| CYP1A2-inh | 0.196 |
| CYP1A2-sub | 0.802 |
| CYP2c19-inh | 0.139 |
| CYP2c19-sub | 0.321 |
| CYP2c9-inh | 0.353 |
| CYP2c9-sub | 0.779 |
| CYP2d6-inh | 0.05 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.109 |
| CYP3a4-sub | 0.533 |
| CL | 2.595 |
| T12 | 0.031 |
| hERG | 0.221 |
| Ames | 0.01 |
| ROA | 0.04 |
| SkinSen | 0.845 |
| Carcinogencity | 0.052 |
| EI | 0.023 |
| Respiratory | 0.947 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.592112 |